ArticleEuropean urology open science2025

Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence.

Marco Finati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.